RT Journal Article
T1 Spanish Society of Cardio & Endovascular Surgery registry of interventions in patients with congenital heart disease: 2020, and retrospective of the previous 9 years
A1 Polo Lopez, Luz
A1 Centella Hernandez, Tomasa
A1 Cuerpo Caballero, Gregorio
A1 Lopez Menendez, Jose
A1 Carnero Alcazar, Manuel
A1 Garcia Fuster, Rafael
A1 Gascon Garcia-Verdugo, Pilar
A1 Barquero Aroca, Jose Miguel
K1 Cardiovascular surgery
K1 Congenital heart disease
K1 Registry
K1 Spain
K1 Prevalence
K1 Outcomes
AB The Spanish Society of Cardiovascular & Endovascular Surgery presents the 2012-2020 report of the activity in congenital cardiovascular surgery, based on a voluntary and anonymous registration involving the most of Spanish centres. This article is complementary to the 2020 cardiovascular surgery annual report, and they are published together. In 2020, seriously damaged by the COVID-19 pandemic related to all sanitary fields, we observe a 14% drop in our congenital activity compared with 2019. Data from the previous 9 years are included, in order to obtain real information related to our activity in the serelatively scarce pathologies. In the last nine years, a total of 18526 congenital heart surgeries were performed, accounting for 9.6% of major surgery (congenital + acquired) performed in Spain during that period. Of these surgeries, 81% of them required extracorporeal circulation and 19% not. We highlight the interventions in neonates and adult patients, which represent respectively 19% and 21% of the whole activity and are a real challenge. The most prevalent congenital heart pathologies operated on were septal defects in cases requiring extracorporeal circulation, and ductus in patients not requiring extracorporeal circulation. The presented data are adjusted to the basic Aristotle score of preoperative surgical risk. The observed mortality of surgeries with extracorporeal circulation was 3.1% (Aristotle-6.48), and without cardiopulmonary bypass 2.41% (Aristotle-4.81). This data analysis shows accurate and reliable information about our surgery for congenital heart disease and allow us to compare ourselves within an international framework, and to organize strategies directed to improve our results. (C) 2022 Published by Elsevier Espana, S.L.U. on behalf of Sociedad Espanola de Cirugia Cardiovascular y Endovascular.
PB Elsevier
SN 1134-0096
YR 2022
FD 2022-07-09
LK http://hdl.handle.net/10668/22094
UL http://hdl.handle.net/10668/22094
LA es
DS RISalud
RD Apr 12, 2025